The Pharmaceutical Packaging Market Size accounted for USD 121.7 Billion in 2022 and is estimated to achieve a market size of USD 352.5 Billion by 2032 growing at a CAGR of 11.4% from 2023 to 2032.
Pharmaceutical Packaging Market Highlights
- Global pharmaceutical packaging market revenue is poised to garner USD 352.5 billion by 2032 with a CAGR of 11.4% from 2023 to 2032
- North America pharmaceutical packaging market value occupied around USD 46.3 billion in 2022
- Asia-Pacific pharmaceutical packaging market growth will record a CAGR of more than 13% from 2023 to 2032
- Among product, the primary sub-segment generated more than USD 92.5 billion revenue in 2022
- Based on end-use, the pharma manufacturing sub-segment generated around 49% market share in 2022
- Integration of digital technologies for enhanced tracking and monitoring of pharmaceutical products is a popular pharmaceutical packaging market trend that fuels the industry demand
Pharmaceutical packaging is the process of packaging pharmaceutical medicines using a variety of raw materials such as glass and plastic resins. As the pharmaceutical business becomes more sophisticated and diverse, developing nations are likely to drive worldwide demand. Advances in drug delivery technology are expected to propel the oral sector to the forefront in the pharmaceutical packaging market forecast period. Oral medicines, which are often used for broad drug administration, provide a simple and effective way to administer pharmaceuticals. As demand for oral pharmaceuticals increases, so will the need for creative and efficient pharmaceutical packaging solutions.
Global Pharmaceutical Packaging Market Dynamics
Market Drivers
- Increasing demand for pharmaceutical products globally
- Technological advancements in packaging materials and processes
- Stringent regulatory requirements for product safety and integrity
- Growing emphasis on patient convenience and compliance
Market Restraints
- High initial investment costs for advanced packaging technologies
- Challenges associated with regulatory compliance and approvals
- Environmental concerns related to packaging waste and sustainability
Market Opportunities
- Rising adoption of innovative packaging solutions such as smart packaging and anti-counterfeiting measures
- Expansion of pharmaceutical markets in emerging economies
- Growing demand for specialized packaging for biologics and personalized medicine
Pharmaceutical Packaging Market Report Coverage
| Market |
Pharmaceutical Packaging Market
|
| Pharmaceutical Packaging Market Size 2022 |
USD 121.7 Billion |
| Pharmaceutical Packaging Market Forecast 2032 |
USD 352.5 Billion
|
| Pharmaceutical Packaging Market CAGR During 2023 - 2032 |
11.4% |
| Pharmaceutical Packaging Market Analysis Period |
2020 - 2032 |
Pharmaceutical Packaging Market Base Year
|
2022 |
| Pharmaceutical Packaging Market Forecast Data |
2023 - 2032 |
| Segments Covered |
By Material, By Product, By Drug Delivery Mode, By End-Use, And By Geography
|
| Regional Scope |
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
| Key Companies Profiled |
Catalent, Inc., Becton, Dickinson and Company, International Paper, Berry Global Inc., Nipro Corporation, Amcor Plc, Comar, LLC, CCL Industries, Inc., Owens Illinois Inc., Drug Plastics Group, Aptargroup, Inc., and Gerresheimer AG.
|
Report Coverage
|
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Covid-19 Analysis, Regulation Analysis |
Pharmaceutical Packaging Market Insights
The pharmaceutical industry presents significant development opportunities for emerging economies such as China, India, and Brazil, which boast enormous potential in the pharmaceutical packaging market. Increasing life expectancy and higher disposable incomes further contribute to appealing growth prospects as companies seek to navigate stagnant mature markets, expiring patents, and increasing regulatory barriers.
Notably, a shift has been observed in the establishment of health infrastructure in these countries. Therefore, it is not feasible for emerging markets to adopt a one-size-fits-all strategy. Local peculiarities necessitate specific solutions tailored to these markets, particularly among the primary clusters of markets, including the economies of BRICMT (Brazil, Russia, India, China, Mexico, and Turkey).
Turkey, and the second-level nations in Southeast Asia, and Africa.
In 2022, the US dominated the North American market, representing the majority share. It is also recognized as the world's largest pharmaceutical market. The country's robust healthcare system, high per capita incomes, and significant investments in drug development are expected to drive growth in the pharmaceutical packaging industry.
However, recent uncertainties regarding the US government have led to hesitancy among major pharmaceutical clients, resulting in a decline in the country's pharmaceutical industry. Nonetheless, the growing importance of generic medicines and improved access to healthcare facilities are anticipated to create opportunities for market growth.
Several plastic vial companies, including Amcor Ltd. Inc., Gerresheimer AG, and Berry Plastics Group, are likely to have a presence in the nation, positively impacting the demand for plastic vials in the sector. The demand for plastics and polymers is expected to advance steadily over the pharmaceutical packaging industry forecast period.
Pharmaceutical Packaging Market Segmentation
The worldwide market for pharmaceutical packaging is split based on material, product, drug delivery mode, end-use, and geography.
Pharmaceutical Packaging Materials
- Plastics & Polymers
- Polyvinyl Chloride (PVC)
- Polypropylene (PP)
- Polyethylene Terephthalate (PET)
- Polyethylene (PE)
- Polystyrene (PS)
- Others
- Paper & Paperboard
- Glass
- Aluminium Foil
- Others
According to pharmaceutical packaging industry analysis, the plastics & polymers category leads the market because to its adaptability, durability, and cost-effectiveness. Plastics and polymers provide a wide range of packaging alternatives, such as bottles, containers, blister packs, and flexible packaging choices such as pouches and film. These materials have exceptional barrier qualities, protecting pharmaceuticals from moisture, light, and contamination. Furthermore, plastics and polymers are lightweight, lowering transportation costs and carbon footprints. Their adaptability enables novel package designs and customization to meet individual product needs. With rising global demand for pharmaceutical items, the plastics & polymers segment is likely to continue its market leadership by providing effective and dependable packaging solutions for a wide range of healthcare products.
Pharmaceutical Packaging Products
- Primary
- Plastic Bottles
- Caps & Closures
- Parenteral Containers
- Syringes
- Vials & Ampoules
- Others
- Blister Packs
- Prefillable Inhalers
- Pouches
- Medication Tubes
- Others
- Secondary
- Prescription Containers
- Pharmaceutical Packaging Accessories
- Tertiary
The primary category dominates the pharmaceutical packaging market because it includes packaging materials that are directly in touch with pharmaceutical medicines. This comprises bottles, vials, blister packs, and ampoules, among other things. The primary packaging is critical for maintaining product integrity, preventing contamination, and guaranteeing accurate dose administration. It frequently has child-resistant closures and tamper-evident seals to improve safety. Furthermore, primary packaging is important for product identification and branding, which helps to build consumer confidence and loyalty. With increased global demand for pharmaceutical goods, the primary sector is likely to maintain its market leadership, driven by advancements in materials, designs, and technologies to suit changing industry requirements and customer preferences.
Pharmaceutical Packaging Drug Delivery Modes
- Oral Drugs
- Injectables
- Topical
- Ocular/ Ophthalmic
- Nasal
- Pulmonary
- Transdermal
- IV Drugs
- Others
For a variety of reasons, the oral drugs sector holds the highest share of the pharmaceutical packaging market. For starters, oral medications are among the most commonly prescribed and consumed pharmaceutical goods in the world, greatly increasing demand for packaging solutions. Second, oral medicine packaging frequently uses a number of formats such as tablets, capsules, and liquid formulations, necessitating a wide range of packaging solutions to accommodate varying dosage forms. Furthermore, patients often take oral drugs alone, necessitating user-friendly and tamper-evident container designs to guarantee optimum dose adherence and product safety. With the increased frequency of chronic illnesses and an ageing population, demand for oral drugs is likely to rise further, strengthening the oral drugs segment's dominance in the pharmaceutical packaging market.
Pharmaceutical Packaging End-Uses
- Pharma Manufacturing
- Contract Packaging
- Retail Pharmacy
- Institutional Pharmacy
In the pharmaceutical manufacturing, the leading market share in 2022 exceeded 49%. During the forecast period, this segment is expected to maintain its prominence. The growing population and increasing demand for better healthcare services are anticipated to positively impact the pharmaceutical sector's development over the forecast era. Furthermore, growing public support for the industry's growth in emerging countries is likely to drive packaging demand in the coming years.
Manufacturers increasingly prefer outsourcing packaging operations to third-party suppliers, which can drive demand for contract packaging. Outsourcing packaging operations has been enhanced to save time and costs for pharmaceutical industry players. Rather than investing in their own packaging, pharmaceutical companies are outsourcing employment to dedicated and competent contractors. The demand for the contract packaging segment is expected to be driven by these factors over the forecast period.
Rapid financial growth has led to improved prosperity and government health initiatives in Brazil, China, Mexico, Russia, India, and Turkey, resulting in increased demand for pharmaceuticals. This trend in manufacturing, which subsequently increases demand, has reduced the cost of pharmaceutical products. These factors are expected to positively influence business development during the forecast period.
Pharmaceutical Packaging Market Regional Outlook
North America
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- India
- Japan
- China
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
The Middle East & Africa
- South Africa
- GCC Countries
- Rest of the Middle East & Africa (ME&A)
Pharmaceutical Packaging Market Regional Analysis
In terms of pharmaceutical packaging market analysis, in 2022, North America accounted for over 38% of the market share, driven by an increase in the production of child-resistant packaging products. Additionally, the growing manufacturing of branded medicines, which require more packaging components to protect the medication from external factors, further supports regional product demand. The presence of leading producers of branded medicines, including Johnson & Johnson, Merck (Schering-Plough Canada Inc.), Pfizer, Sanofi-Aventis (Sanofi Pasteur), and GlaxoSmithKline Inc., also contributed to national development.
Asia-Pacific is projected to grow at the highest CAGR of approximately 13% during the forecast period. This growth is attributed to the increasing popularity of rigid plastics, particularly polyethylene terephthalate (PET) and polyethylene (PPE), as primary materials used in product manufacturing. The regional economy's development has been bolstered by heightened public regulations on drug safety. The use of pharmaceutical packaging is crucial to safeguard drugs from external environmental factors, underscoring its importance in ensuring drug safety.
Pharmaceutical Packaging Market Players
Some of the top pharmaceutical packaging companies offered in our report includes Catalent, Inc., Becton, Dickinson and Company, International Paper, Berry Global Inc., Nipro Corporation, Amcor Plc, Comar, LLC, CCL Industries, Inc., Owens Illinois Inc., Drug Plastics Group, Aptargroup, Inc., and Gerresheimer AG.
CHAPTER 1. Industry Overview of Pharmaceutical Packaging Market
1.1. Definition and Scope
1.1.1. Definition of Pharmaceutical Packaging
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Pharmaceutical Packaging Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Pharmaceutical Packaging Market By Material
1.2.3. Pharmaceutical Packaging Market By Product
1.2.4. Pharmaceutical Packaging Market By Drug Delivery Mode
1.2.5. Pharmaceutical Packaging Market By End-Use
1.2.6. Pharmaceutical Packaging Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Pharmaceutical Packaging Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Pharmaceutical Packaging Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2022
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022
4.2. R&D Status of Major Manufacturers in 2022
CHAPTER 5. Pharmaceutical Packaging Market By Material
5.1. Introduction
5.2. Pharmaceutical Packaging Revenue By Material
5.2.1. Pharmaceutical Packaging Revenue (USD Billion) and Forecast, By Material, 2020-2032
5.2.2. Plastics & Polymers
5.2.2.1. Plastics & Polymers Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.2.2. Polyvinyl Chloride (PVC)
5.2.2.2.1. Polyvinyl Chloride (PVC) Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.2.3. Polypropylene (PP)
5.2.2.3.1. Polypropylene (PP) Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.2.4. Polyethylene Terephthalate (PET)
5.2.2.4.1. Polyethylene Terephthalate (PET) Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.2.5. Polyethylene (PE)
5.2.2.5.1. Polyethylene (PE) Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.2.6. Polystyrene (PS)
5.2.2.6.1. Polystyrene (PS) Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.2.7. Others
5.2.2.7.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3. Paper & Paperboard
5.2.3.1. Paper & Paperboard Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.4. Glass
5.2.4.1. Glass Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.5. Aluminium Foil
5.2.5.1. Aluminium Foil Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.6. Others
5.2.6.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 6. Pharmaceutical Packaging Market By Product
6.1. Introduction
6.2. Pharmaceutical Packaging Revenue By Product
6.2.1. Pharmaceutical Packaging Revenue (USD Billion) and Forecast, By Product, 2020-2032
6.2.2. Primary
6.2.2.1. Primary Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.2.2. Plastic Bottles
6.2.2.2.1. Plastic Bottles Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.2.3. Caps & Closures
6.2.2.3.1. Caps & Closures Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.2.4. Parenteral Containers
6.2.2.4.1. Parenteral Containers Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.2.4.2. Syringes
6.2.2.4.2.1. Syringes Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.2.4.3. Vials & Ampoules
6.2.2.4.3.1. Vials & Ampoules Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.2.4.4. Others
6.2.2.4.4.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.2.5. Blister Packs
6.2.2.5.1. Blister Packs Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.2.6. Prefillable Inhalers
6.2.2.6.1. Prefillable Inhalers Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.2.7. Pouches
6.2.2.7.1. Pouches Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.2.8. Medication Tubes
6.2.2.8.1. Medication Tubes Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.2.9. Others
6.2.2.9.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3. Secondary
6.2.3.1. Secondary Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3.2. Prescription Containers
6.2.3.2.1. Prescription Containers Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3.3. Pharmaceutical Packaging Accessories
6.2.3.3.1. Pharmaceutical Packaging Accessories Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.4. Tertiary
6.2.4.1. Tertiary Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 7. Pharmaceutical Packaging Market By Drug Delivery Mode
7.1. Introduction
7.2. Pharmaceutical Packaging Revenue By Drug Delivery Mode
7.2.1. Pharmaceutical Packaging Revenue (USD Billion) and Forecast, By Drug Delivery Mode, 2020-2032
7.2.2. Oral Drugs
7.2.2.1. Oral Drugs Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.3. Injectables
7.2.3.1. Injectables Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.4. Topical
7.2.4.1. Topical Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.5. Ocular/ Ophthalmic
7.2.5.1. Ocular/ Ophthalmic Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.6. Nasal
7.2.6.1. Nasal Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.7. Pulmonary
7.2.7.1. Pulmonary Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.8. Transdermal
7.2.8.1. Transdermal Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.9. IV Drugs
7.2.9.1. IV Drugs Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.10. Others
7.2.10.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 8. Pharmaceutical Packaging Market By End-use
8.1. Introduction
8.2. Pharmaceutical Packaging Revenue By End-use
8.2.1. Pharmaceutical Packaging Revenue (USD Billion) and Forecast, By End-use, 2020-2032
8.2.2. Pharma Manufacturing
8.2.2.1. Pharma Manufacturing Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
8.2.3. Contract Packaging
8.2.3.1. Contract Packaging Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
8.2.4. Retail Pharmacy
8.2.4.1. Retail Pharmacy Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
8.2.5. Institutional Pharmacy
8.2.5.1. Institutional Pharmacy Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 9. North America Pharmaceutical Packaging Market By Country
9.1. North America Pharmaceutical Packaging Market Overview
9.2. U.S.
9.2.1. U.S. Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Product, 2020-2032
9.2.2. U.S. Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Material, 2020-2032
9.2.3. U.S. Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Drug Delivery Mode, 2020-2032
9.2.4. U.S. Pharmaceutical Packaging Revenue (USD Billion) and Forecast By End-use, 2020-2032
9.3. Canada
9.3.1. Canada Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Product, 2020-2032
9.3.2. Canada Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Material, 2020-2032
9.3.3. Canada Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Drug Delivery Mode, 2020-2032
9.3.4. Canada Pharmaceutical Packaging Revenue (USD Billion) and Forecast By End-use, 2020-2032
9.4. North America PEST Analysis
CHAPTER 10. Europe Pharmaceutical Packaging Market By Country
10.1. Europe Pharmaceutical Packaging Market Overview
10.2. U.K.
10.2.1. U.K. Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Product, 2020-2032
10.2.2. U.K. Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Material, 2020-2032
10.2.3. U.K. Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Drug Delivery Mode, 2020-2032
10.2.4. U.K. Pharmaceutical Packaging Revenue (USD Billion) and Forecast By End-use, 2020-2032
10.3. Germany
10.3.1. Germany Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Product, 2020-2032
10.3.2. Germany Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Material, 2020-2032
10.3.3. Germany Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Drug Delivery Mode, 2020-2032
10.3.4. Germany Pharmaceutical Packaging Revenue (USD Billion) and Forecast By End-use, 2020-2032
10.4. France
10.4.1. France Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Product, 2020-2032
10.4.2. France Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Material, 2020-2032
10.4.3. France Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Drug Delivery Mode, 2020-2032
10.4.4. France Pharmaceutical Packaging Revenue (USD Billion) and Forecast By End-use, 2020-2032
10.5. Spain
10.5.1. Spain Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Product, 2020-2032
10.5.2. Spain Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Material, 2020-2032
10.5.3. Spain Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Drug Delivery Mode, 2020-2032
10.5.4. Spain Pharmaceutical Packaging Revenue (USD Billion) and Forecast By End-use, 2020-2032
10.6. Rest of Europe
10.6.1. Rest of Europe Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Product, 2020-2032
10.6.2. Rest of Europe Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Material, 2020-2032
10.6.3. Rest of Europe Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Drug Delivery Mode, 2020-2032
10.6.4. Rest of Europe Pharmaceutical Packaging Revenue (USD Billion) and Forecast By End-use, 2020-2032
10.7. Europe PEST Analysis
CHAPTER 11. Asia Pacific Pharmaceutical Packaging Market By Country
11.1. Asia Pacific Pharmaceutical Packaging Market Overview
11.2. China
11.2.1. China Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Product, 2020-2032
11.2.2. China Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Material, 2020-2032
11.2.3. China Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Drug Delivery Mode, 2020-2032
11.2.4. China Pharmaceutical Packaging Revenue (USD Billion) and Forecast By End-use, 2020-2032
11.3. Japan
11.3.1. Japan Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Product, 2020-2032
11.3.2. Japan Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Material, 2020-2032
11.3.3. Japan Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Drug Delivery Mode, 2020-2032
11.3.4. Japan Pharmaceutical Packaging Revenue (USD Billion) and Forecast By End-use, 2020-2032
11.4. India
11.4.1. India Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Product, 2020-2032
11.4.2. India Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Material, 2020-2032
11.4.3. India Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Drug Delivery Mode, 2020-2032
11.4.4. India Pharmaceutical Packaging Revenue (USD Billion) and Forecast By End-use, 2020-2032
11.5. Australia
11.5.1. Australia Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Product, 2020-2032
11.5.2. Australia Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Material, 2020-2032
11.5.3. Australia Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Drug Delivery Mode, 2020-2032
11.5.4. Australia Pharmaceutical Packaging Revenue (USD Billion) and Forecast By End-use, 2020-2032
11.6. South Korea
11.6.1. South Korea Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Product, 2020-2032
11.6.2. South Korea Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Material, 2020-2032
11.6.3. South Korea Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Drug Delivery Mode, 2020-2032
11.6.4. South Korea Pharmaceutical Packaging Revenue (USD Billion) and Forecast By End-use, 2020-2032
11.7. Rest of Asia-Pacific
11.7.1. Rest of Asia-Pacific Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Product, 2020-2032
11.7.2. Rest of Asia-Pacific Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Material, 2020-2032
11.7.3. Rest of Asia-Pacific Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Drug Delivery Mode, 2020-2032
11.7.4. Rest of Asia-Pacific Pharmaceutical Packaging Revenue (USD Billion) and Forecast By End-use, 2020-2032
11.8. Asia Pacific PEST Analysis
CHAPTER 12. Latin America Pharmaceutical Packaging Market By Country
12.1. Latin America Pharmaceutical Packaging Market Overview
12.2. Brazil
12.2.1. Brazil Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Product, 2020-2032
12.2.2. Brazil Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Material, 2020-2032
12.2.3. Brazil Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Drug Delivery Mode, 2020-2032
12.2.4. Brazil Pharmaceutical Packaging Revenue (USD Billion) and Forecast By End-use, 2020-2032
12.3. Mexico
12.3.1. Mexico Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Product, 2020-2032
12.3.2. Mexico Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Material, 2020-2032
12.3.3. Mexico Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Drug Delivery Mode, 2020-2032
12.3.4. Mexico Pharmaceutical Packaging Revenue (USD Billion) and Forecast By End-use, 2020-2032
12.4. Rest of Latin America
12.4.1. Rest of Latin America Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Product, 2020-2032
12.4.2. Rest of Latin America Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Material, 2020-2032
12.4.3. Rest of Latin America Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Drug Delivery Mode, 2020-2032
12.4.4. Rest of Latin America Pharmaceutical Packaging Revenue (USD Billion) and Forecast By End-use, 2020-2032
12.5. Latin America PEST Analysis
CHAPTER 13. Middle East & Africa Pharmaceutical Packaging Market By Country
13.1. Middle East & Africa Pharmaceutical Packaging Market Overview
13.2. GCC
13.2.1. GCC Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Product, 2020-2032
13.2.2. GCC Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Material, 2020-2032
13.2.3. GCC Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Drug Delivery Mode, 2020-2032
13.2.4. GCC Pharmaceutical Packaging Revenue (USD Billion) and Forecast By End-use, 2020-2032
13.3. South Africa
13.3.1. South Africa Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Product, 2020-2032
13.3.2. South Africa Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Material, 2020-2032
13.3.3. South Africa Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Drug Delivery Mode, 2020-2032
13.3.4. South Africa Pharmaceutical Packaging Revenue (USD Billion) and Forecast By End-use, 2020-2032
13.4. Rest of Middle East & Africa
13.4.1. Rest of Middle East & Africa Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Product, 2020-2032
13.4.2. Rest of Middle East & Africa Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Material, 2020-2032
13.4.3. Rest of Middle East & Africa Pharmaceutical Packaging Revenue (USD Billion) and Forecast By Drug Delivery Mode, 2020-2032
13.4.4. Rest of Middle East & Africa Pharmaceutical Packaging Revenue (USD Billion) and Forecast By End-use, 2020-2032
13.5. Middle East & Africa PEST Analysis
CHAPTER 14. Player Analysis Of Pharmaceutical Packaging Market
14.1. Pharmaceutical Packaging Market Company Share Analysis
14.2. Competition Matrix
14.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
14.2.2. New Product Launches and Product Enhancements
14.2.3. Mergers And Acquisition In Global Pharmaceutical Packaging Market
14.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 15. Company Profile
15.1. Catalent, Inc.
15.1.1. Company Snapshot
15.1.2. Business Overview
15.1.3. Financial Overview
15.1.3.1. Revenue (USD Billion), 2022
15.1.3.2. Catalent, Inc. 2022 Pharmaceutical Packaging Business Regional Distribution
15.1.4. Product /Service and Specification
15.1.5. Recent Developments & Business Strategy
15.2. Becton
15.3. Dickinson and Company
15.4. International Paper
15.5. Berry Global Inc.
15.6. Nipro Corporation
15.7. Amcor Plc
15.8. Comar, LLC
15.9. CCL Industries, Inc.
15.10. Owens Illinois Inc.
15.11. Drug Plastics Group
15.12. Aptargroup, Inc.
15.13. Gerresheimer AG
